ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker.
In this article:
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..